Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICE IV: Early Dexmedetomidine Sedation in Older Ventilated ICU Patients
2022-501157-36-00Phase 4Authorised
- Sponsor
- Monash University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 4, randomised, double-blind trial in Not applicable (not a disease) comparing Dexmedetomidine early sedation with Placebo early sedation (2 arms). Primary endpoint: 90-day all-cause mortality. Planned start Feb 2024; status: authorised.
02
Drugs
dexmedetomidine
03
Conditions
Not applicable (not a disease)
Beyond the preview
Go deeper on 2022-501157-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-501157-36-00.